Oruka Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Oruka Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Oruka Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $23K, a 30.3% decline year-over-year.
  • Oruka Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $127K, a 3.05% decline from 2022.
  • Oruka Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $131K, a 56% increase from 2021.
  • Oruka Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $84K, unchanged from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $127K -$4K -3.05% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-01
2022 $131K +$47K +56% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-01
2021 $84K $0 0% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-24
2020 $84K +$8K +10.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $76K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.